Roche Finally Gets Nod With Sweetened $3.4 Billion Bid For Ventana

After seven months and a half-dozen attempts at acquiring tissue-based cancer test maker Ventana Medical Systems, Roche finally won over the firm's board with a sweetened bid worth $3.4 billion